![Medtronic PROTECTA XT DR D314DRG Скачать руководство пользователя страница 22](http://html.mh-extra.com/html/medtronic/protecta-xt-dr-d314drg/protecta-xt-dr-d314drg_clinician-manual_1763148022.webp)
Note: Patient-activated cardioversion is delivered only if the implanted device is
currently detecting an AT/AF episode and the physician has programmed the device to
allow patient-activated cardioversion.
Contents of sterile package – The package contains one implantable cardioverter
defibrillator, one torque wrench, and one DF-1 pin plug.
1.3 Indications and usage
The Protecta XT DR system is indicated to provide ventricular antitachycardia pacing and
ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.
In addition, the device is indicated for use in patients with atrial tachyarrhythmias, or those
patients who are at significant risk of developing atrial tachyarrhythmias.
Notes:
●
The use of the device has not been demonstrated to decrease the morbidity related to
atrial tachyarrhythmias.
●
The effectiveness of high-frequency burst pacing (atrial 50 Hz Burst therapy) in
terminating device classified atrial tachycardia (AT) was found to be 17%, and in
terminating device classified atrial fibrillation (AF) was found to be 16.8%, in the VT/AT
patient population studied.
●
The effectiveness of high-frequency burst pacing (atrial 50 Hz Burst therapy) in
terminating device classified atrial tachycardia (AT) was found to be 11.7%, and in
terminating device classified atrial fibrillation (AF) was found to 18.2% in the AF-only
patient population studied.
1.4 Contraindications
The Protecta XT DR system is contraindicated for patients experiencing tachyarrhythmias
with transient or reversible causes including, but not limited to, the following: acute
myocardial infarction, drug intoxication, drowning, electric shock, electrolyte imbalance,
hypoxia, or sepsis.
The device is contraindicated for patients who have a unipolar pacemaker implanted.
The device is contraindicated for patients with incessant VT or VF.
The device is contraindicated for patients whose primary disorder is chronic atrial
tachyarrhythmia with no concomitant VT or VF.
Medtronic
PROTECTA™ XT DR D314DRG
22
Clinician Manual
Содержание PROTECTA XT DR D314DRG
Страница 2: ......
Страница 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Страница 506: ......
Страница 507: ......